Surgical debulking of large ventricular fibromas in children
The Journal of Thoracic and Cardiovascular Surgery · 2025
DOI: 10.1016/j.jtcvs.2024.05.013 ↗Kurz gefasst
Video/Audio in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2025. Verfasst von Ajami Gikandi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Mass. Hauptthemen laut MEDLINE: Fibroma, Heart Ventricles, Heart Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
OBJECTIVE: This study aims to provide an update on the clinical presentation, diagnostic workup, operative strategies, and midterm outcomes in children undergoing ventricular fibroma resection. METHODS: Single-center, retrospective cohort study of patients undergoing ventricular fibroma resection between 2000 and 2023. RESULTS: Among 52 patients, median age at surgery was 2.0 years (interquartile range, 0.8-4.6) and median tumor volume index was 69 mL/m2 (interquartile range, 49-169). Tumor distorted the atrioventricular valve/subvalvar apparatus in 30 patients (58%) and abutted major epicardial coronary arteries in 41 patients (79%). Surgery was indicated for arrythmia (n = 45, 86%), symptoms (n = 14, 27%), or hemodynamic compromise (n = 11, 21%). Tumor was debulked in 34 patients (65%), including the last 21 patients. Concomitant atrioventricular valvuloplasty was performed in 18 patients and ventricular cavity closure in 15 patients (29%). During a median follow-up of 2.4 years (interquartile range, 0.8-6.2), there was no mortality, cardiac arrests, heart transplants, or single ventricle palliation. The 15-year risk of reoperation and clinical ventricular tachycardia/fibrillation was 6.7% (95% CI, 0-14.3) and 2.4% (95% CI, 0-7.2), respectively. On latest imaging, pre- and postdebulking left ventricular ejection fraction did not significantly differ (P = .069), whereas no patients had signs of outflow tract obstruction, inflow tract obstruction, or moderate or greater atrioventricular valve regurgitation. CONCLUSIONS: Large ventricular fibromas can be resected safely with appropriate surgical planning and an emphasis on debulking. Most children maintain left ventricular function and remain free of recurrent ventricular arrhythmias at follow-up. Extended follow-up is warranted to understand whether patients remain at risk for scar-based ventricular arrhythmias in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
- Division of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
- Division of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Mass. Electronic address: pedro.delnido@cardio.chboston.org.
Zitieren
APA
Gikandi, A., Chiu, P., Secor, J., Nathan, M., O'Leary, E., Walsh, E., Geva, T., Beroukhim, R., & Del Nido, P. (2025). Surgical debulking of large ventricular fibromas in children. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2024.05.013
Vancouver
Gikandi A, Chiu P, Secor J, Nathan M, O'Leary E, Walsh E, et al. Surgical debulking of large ventricular fibromas in children. The Journal of Thoracic and Cardiovascular Surgery. 2025. doi:10.1016/j.jtcvs.2024.05.013
BibTeX
@article{Gikandi2025,
author = {Gikandi, Ajami and Chiu, Peter and Secor, Jordan and Nathan, Meena and O'Leary, Edward and Walsh, Edward and Geva, Tal and Beroukhim, Rebecca and Del Nido, Pedro},
title = {Surgical debulking of large ventricular fibromas in children},
journal = {The Journal of Thoracic and Cardiovascular Surgery},
year = {2025},
doi = {10.1016/j.jtcvs.2024.05.013}
}
EUVIMED